You are here: Home » Companies » News
Business Standard

Dr Reddy's launches anti-depressant, muscle relaxant tablets in US

Launches Bupropion Hydrochloride extended-release tablets USP in strengths of 150 mg and 300 mg

BS Reporter  |  Hyderabad 

Dr Reddy's launches two generic products in US

Dr Reddy's Laboratories Limited announced on Wednesday that it has launched anti-depressant, Bupropion Hydrochloride Extended Release Tablets, 150 mg and 300 mg, as well as muscle relaxant drug Metaxalone in the market.

The anti-depressant drug is a generic equivalent version of Wellbutrin XL, a trademark of The brand and generic sales of the drug was approximately $754 million for the recent twelve months ending July 2017, according to IMS Health.

It may be recalled that Indian generic and had launched Wellbutrin's of 150 mg and 300 mg dose tablets in April 2016 and June 2017 respectively.

However, the of (100 mg, 150 mg and 200 mg) is being sold by Dr Reddy's since September 2016.

Metaxalone, which is used for the treatment of skeletal muscle conditions such as pain and injury, is a generic equivalent version of the Skelaxin brand of King Pharmaceuticals Research and Development, Inc. The brand and generics of this drug had sales of around $129 million during the same period as per

First Published: Wed, September 06 2017. 15:21 IST